Bionet (1784) — Cash Flow Quality Index
Bionet (1784) has a Cash Flow Quality Index of 1.94x as of December 2025. Operating cash flow of NT$28.46 Million exceeds net income of NT$14.71 Million, indicating high earnings quality where cash backs reported profits. Also explore 1784 current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bionet Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bionet across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Bionet tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Bionet (2018–2025)
Year-by-year earnings quality comparison for Bionet. For live market cap and the full company financial profile, see market cap of Bionet.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | NT$148.04 Million | NT$51.43 Million | ▲ +36.5% |
| 2024 | 2.11x | NT$176.49 Million | NT$83.70 Million | ▲ +47.5% |
| 2023 | 1.43x | NT$153.09 Million | NT$107.08 Million | ▼ -42.6% |
| 2022 | 2.49x | NT$94.65 Million | NT$37.97 Million | ▲ +639.8% |
| 2021 | 0.34x | NT$13.88 Million | NT$41.19 Million | ▼ -97.1% |
| 2020 | 11.47x | NT$73.66 Million | NT$6.42 Million | ▲ +2823.6% |
| 2019 | 0.39x | NT$2.67 Million | NT$6.80 Million | ▲ +173.3% |
| 2018 | -0.54x | NT$-12.97 Million | NT$24.23 Million | — |